跳至主要内容
临床试验/NCT04776928
NCT04776928已完成不适用

Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing - Aim 3 Phase 1

University of Michigan1 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2022年3月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
217
试验地点
1
主要终点
Change in Opioid Prescribed Following the Intervention

研究概览

简要总结

The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives.

The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing.

The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants).

The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Surgeons already participating in and sharing data with the Michigan Surgical Quality Collaborative (MSQC) who perform procedures of interest
  • •Surgeons within MSQC who have median prescribing > 1 pill equivalents over the published recommendation
  • •Surgeons within MSQC who perform surgeries at a hospital that have agreed to participate in this research

排除标准

  • •Surgeons not identified in the MSQC data as having a valid National Provider Identifier (NPI)

研究组 & 干预措施

Provider-level push report notifications

Experimental

Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site.

干预措施: Push reports (Behavioral)

No intervention

No Intervention

Sites who did not sign Exhibit B-1.

结局指标

主要结局

Change in Opioid Prescribed Following the Intervention

时间窗: up to 5 months from enrollment

Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Waljee

Associate Professor of Surgery and Associate Professor of Orthopaedic Surgery

University of Michigan

研究点 (1)

Loading locations...

相似试验